GLS2 and central nervous system cancer: Furthermore, ADAR1 was shown to be involved in the impairment of TMZ resistance in glioma stabilizing glutaminase 2 (GLS2) mRNA, involved in the ferroptosis pathway by lipid metabolism [50].